Article
Medically Actionable Secondary Findings from Whole Exome Sequencing (WES) Data in a Sample of 3,972 Individuals
2025-03-17
Abstract excerpt
The application of whole-exome sequencing (WES) for diagnostic purposes has the potential to unravel secondary findings unrelated with the primary reason of testing. Some of those might be of high clinical utility and comprise disease-causing variants in genes, related to lifethreatening and clinically actionable diseases. Clarifying the allelic frequencies of such variants in specific populations is a crucial ste...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e0549d3d-74b9-57cc-8aae-29964cf39623
- DOI
- 10.20944/preprints202503.1095.v1
